论文信息 - Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies. - 字舞流文

Safety and antitumor activity of biweekly MDX-1106 (Anti-PD-1, BMS-936558/ONO-4538) in patients with advanced refractory malignancies.

David C. Smith | J. Wolchok | C. Drake | M. Sznol | I. Lowy | S. Topalian | D. Lawrence | J. Brahmer | D. McDermott | J. Powderly